JPC-01K

JLK Inc.

JPC-01K is an AI medical system that detects the area of prostate cancer using multiparametric MR images. The system is based on artificial neural networks to analyze the MR images of the prostate cancer patients. The system uses multiparametric MR images, T2, DWI, and DCE, as input and visualizes the location of the prostate cancer and their probability.

Information source: Vendor
Last updated: July 1, 2020

General Information

General
Product name	JPC-01K
Company	JLK Inc.
Subspeciality	Abdomen
Modality	MR
Disease targeted	Prostate cancer
Key-features	Prostate cancer detection
Suggested use	During: perception aid (prompting all abnormalities/results/heatmaps), report suggestion

Technical Specifications

Data characteristics
Population	all prostate MR
Input	multi sequence MR images (T2, DWI(Diffusion Weighted Image), DCE(Dynamic Contrast Enhanced))
Input format	DICOM, JPG
Output	Heatmap overlay, the probability of prostate cancer
Output format	UI, Report
Technology
Integration	Stand-alone third party application, Stand-alone webbased
Deployment	Locally on dedicated hardware, Cloud-based, Hybrid solution
Trigger for analysis	On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time	10 - 60 seconds

Regulatory

Certification
CE	Certified, Class I , MDD
FDA	No or not yet
Intended Use Statements
Intended use (according to CE)

Market

Market presence
On market since	04-2019
Distribution channels
Countries present (clinical, non-research use)	2
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model	Pay-per-use, Subscription
Based on	Number of users, Number of installations

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers